학술논문
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
Document Type
Article
Author
Source
In: Breast Cancer Research and Treatment . (Breast Cancer Research and Treatment, February 2022, 191(3):565-576)
Subject
Language
English
ISSN
15737217
01676806
01676806